免疫检查点抑制剂治疗头颈部鳞状细胞癌:现状和未来方向

Head & neck surgery Pub Date : 2019-10-01 DOI:10.1002/hed.25930

H. Kao, P. Lou

{"title":"免疫检查点抑制剂治疗头颈部鳞状细胞癌:现状和未来方向","authors":"H. Kao, P. Lou","doi":"10.1002/hed.25930","DOIUrl":null,"url":null,"abstract":"Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and activate the immune system to eliminate cancer cells. Head and neck squamous cell carcinoma (HNSCC) is a malignancy with a poor prognosis. The roles of ICIs for HNSCC treatments are emerging.","PeriodicalId":75895,"journal":{"name":"Head & neck surgery","volume":"96 1","pages":"18 - 4"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"40","resultStr":"{\"title\":\"Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions\",\"authors\":\"H. Kao, P. Lou\",\"doi\":\"10.1002/hed.25930\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and activate the immune system to eliminate cancer cells. Head and neck squamous cell carcinoma (HNSCC) is a malignancy with a poor prognosis. The roles of ICIs for HNSCC treatments are emerging.\",\"PeriodicalId\":75895,\"journal\":{\"name\":\"Head & neck surgery\",\"volume\":\"96 1\",\"pages\":\"18 - 4\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"40\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Head & neck surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/hed.25930\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head & neck surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/hed.25930","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 40

摘要

免疫检查点抑制剂(ICIs)可以激活T细胞并激活免疫系统以消除癌细胞。头颈部鳞状细胞癌(HNSCC)是一种预后不良的恶性肿瘤。ICIs在HNSCC治疗中的作用正在逐渐显现。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions

Immune checkpoint inhibitors (ICIs) can reinvigorate T cells and activate the immune system to eliminate cancer cells. Head and neck squamous cell carcinoma (HNSCC) is a malignancy with a poor prognosis. The roles of ICIs for HNSCC treatments are emerging.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Head & neck surgery

自引率

0.00%

发文量